Randall J Lanham - Net Worth and Insider Trading

Randall J Lanham Net Worth

The estimated net worth of Randall J Lanham is at least $7,645 dollars as of 2024-11-13. Randall J Lanham is the General Counsel of Nymox Pharmaceutical Corp and owns about 152,900 shares of Nymox Pharmaceutical Corp (NYMXF) stock worth over $7,645. Details can be seen in Randall J Lanham's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Randall J Lanham has not made any transactions after 2018-10-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Randall J Lanham

To

Randall J Lanham Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Randall J Lanham owns 1 companies in total, including Nymox Pharmaceutical Corp (NYMXF) .

Click here to see the complete history of Randall J Lanham’s form 4 insider trades.

Insider Ownership Summary of Randall J Lanham

Ticker Comapny Transaction Date Type of Owner
NYMXF Nymox Pharmaceutical Corp 2018-10-28 director & General Counsel

Randall J Lanham Latest Holdings Summary

Randall J Lanham currently owns a total of 1 stock. Randall J Lanham owns 152,900 shares of Nymox Pharmaceutical Corp (NYMXF) as of October 28, 2018, with a value of $7,645.

Latest Holdings of Randall J Lanham

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NYMXF Nymox Pharmaceutical Corp 2018-10-28 152,900 0.05 7,645

Holding Weightings of Randall J Lanham


Randall J Lanham Form 4 Trading Tracker

According to the SEC Form 4 filings, Randall J Lanham has made a total of 0 transactions in Nymox Pharmaceutical Corp (NYMXF) over the past 5 years. The most-recent trade in Nymox Pharmaceutical Corp is the acquisition of 2,900 shares on October 28, 2018, which cost Randall J Lanham around $4,988.

Insider Trading History of Randall J Lanham

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Randall J Lanham Trading Performance

GuruFocus tracks the stock performance after each of Randall J Lanham's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randall J Lanham is 26.04%. GuruFocus also compares Randall J Lanham's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randall J Lanham within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Randall J Lanham's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Randall J Lanham

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 10.06 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.86 LIMIT LIMIT LIMIT LIMIT LIMIT

Randall J Lanham Ownership Network

Ownership Network List of Randall J Lanham

No Data

Ownership Network Relation of Randall J Lanham

Insider Network Chart

Randall J Lanham Owned Company Details

What does Nymox Pharmaceutical Corp do?

Who are the key executives at Nymox Pharmaceutical Corp?

Randall J Lanham is the director & General Counsel of Nymox Pharmaceutical Corp. Other key executives at Nymox Pharmaceutical Corp include Chief Financial Officer Erik Danielsen , and director & 10 percent owner & CEO Paul Averback .

Nymox Pharmaceutical Corp (NYMXF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nymox Pharmaceutical Corp (NYMXF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nymox Pharmaceutical Corp (NYMXF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nymox Pharmaceutical Corp (NYMXF)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nymox Pharmaceutical Corp Insider Transactions

No Available Data

Randall J Lanham Mailing Address

Above is the net worth, insider trading, and ownership report for Randall J Lanham. Currently GuruFocus does not have mailing address information for Randall J Lanham.